Association of β-Blocker Use at Time of Radical Prostatectomy With Rate of Treatment for Prostate Cancer Recurrence

por Sivanesan, Shivanthe, Taskén, Kristin Austlid, Grytli, Helene Hartvedt
Publicado 2022

β-Adrenergic Receptor Signaling in Prostate Cancer

por Braadland, Peder Rustøen, Ramberg, Håkon, Grytli, Helene Hartvedt, Taskén, Kristin Austlid
Publicado 2015

Low β(2)-adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolism

por Braadland, Peder Rustøen, Grytli, Helene Hartvedt, Ramberg, Håkon, Katz, Betina, Kellman, Ralf, Gauthier-Landry, Louis, Fazli, Ladan, Krobert, Kurt Allen, Wang, Wanzhong, Levy, Finn Olav, Bjartell, Anders, Berge, Viktor, Rennie, Paul S., Mellgren, Gunnar, Mælandsmo, Gunhild Mari, Svindland, Aud, Barbier, Olivier, Taskén, Kristin Austlid
Publicado 2015